Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
Salma Mawfek Khaled, Nour W. Z. Alhussaini, Majid Alabdulla, Nancy A. Sampson, Ronald C. Kessler, Peter W. Woodruff, Sheik Mohammed Al‐ThaniAbstract
Objectives
To estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time.
Methods
We conducted a national phone survey of 5,195 Qatari and Arab residents in Qatar (2019–2022) using the Composite International Diagnostic Interview Version 3.3 and estimated lifetime mood and anxiety defined diagnoses. Survival‐based discrete time models, lifetime morbid risk, and treatment projections were estimated.
Results
Lifetime prevalence of any disorder was 28.0% and was associated with younger cohorts, females, and migrants, but lower formal education. Treatment contact in the year of disorder onset were 13.5%. The median delay in receiving treatment was 5 years (IQR = 2–13). Lifetime treatment among those with a lifetime disorder were 59.9% for non‐healthcare and 63.5% for healthcare; it was 68.1% for any anxiety and 80.1% for any mood disorder after 50 years of onset. Younger cohorts and later age of onset were significantly predictors of treatment.
Conclusions
Lifetime prevalence of mental disorders in Qatar is comparable to other countries. Treatment is significantly delayed and delivered largely in non‐healthcare sectors thus the need for increased literacy of mental illness to reduce stigma and improve earlier help‐seeking in healthcare settings.